Patent Law Weblog
recent posts
- Retired Judges File Amicus Brief in Support of Judge Newman
- Hikma v. Amarin at the Supreme Court: The Parties’ Opening Briefs
- Teva Pharmaceuticals International v. Eli Lilly & Co. (Fed. Cir. 2026)
- USPTO Extends Artificial Intelligence Search Automated Pilot Program (ASAP!)
- USPTO Announces That It Has Turned the Corner on Unexamined Application Backlog
about
Month: September 2012
-
Strafford will be offering a webinar/teleconference entitled "Biosimilars: Draft FDA Guidance and Emerging Legal Challenges — Navigating FDA's Approval Pathway, Patent Issues, and the Complexities of Exclusivity" on October 23, 2012 from 1:00 – 2:30 pm (EDT). Patent Docs author Dr. Kevin Noonan of McDonnell, Boehnen, Hulbert & Berghoff LLP and Howard W. Levine of…
-
The American Bar Association (ABA) Section of Intellectual Property Law, Section of Science and Technology Law, and Center for Professional Development will be offering a live webinar and teleconference entitled "Single Claim Restriction Requirements: The Interplay Between 35 USC § 112 and 35 USC § 121" on October 2, 2012 from 12:00 – 1:30 pm…
-
Law Seminars International (LSI) will be offering a one-hour telebriefing on the "New Third Circuit Ruling in the K-Dur 'Reverse Payments' Case: Practical Implications for Patent Litigation and FTC Enforcement" on September 20, 2012 from 1:00 – 2:00 pm (Eastern). Jeffrey W. Brennan of McDermott Will & Emery will moderate a panel including Seth C.…
-
By Andrew Williams — Last week, the Federal Circuit partially overturned the U.S. District Court for the District of Delaware's decision in Santarus, Inc. v. Par Pharmaceutical, Inc., thereby allowing Santarus to keep Par's generic version of Zegerid® off the market until the expiration of the Orange Book-listed patents. Judge Newman provided a separate opinion,…
-
By Kevin E. Noonan — Farmer Vernon Hugh Bowman, losing patent infringement defendant in Monsanto Co. v. Bowman, has filed a supplemental brief in response to the brief submitted to the Supreme Court by the Solicitor General pursuant to a request for the Government's views on whether the Court should grant certiorari. The brief raises arguments…
-
By Donald Zuhn — Last week, the U.S. Patent and Trademark Office published a notice of proposed rulemaking in the Federal Register (77 Fed. Reg. 55028) presenting its proposal for setting and adjusting patent fees. In proposing new fees, the Office is exercising the fee setting authority conferred upon it by § 10 of the…
-
By Donald Zuhn — In a Patents Alert e-mail distributed last month, the U.S. Patent and Trademark Office announced that it was examining ways to modernize electronic filing. One proposal, Text2PTO, would allow applicants to submit applications in a text format. According to the Office's Alert, by submitting a text version of the application, applicants…
-
By Sherri Oslick — About Court Report: Each week we will report briefly on recently filed biotech and pharma cases. Teva Branded Pharmaceutical Products R&D Inc. et al. v. Perrigo Pharmaceuticals Co. et al.1:12-cv-01101; filed September 5, 2012 in the District Court of Delaware • Plaintiffs: Teva Branded Pharmaceutical Products R&D Inc.; Teva Respiratory LLC;…
-
September 10-12, 2012 – Business of Biosimilars & Generic Drugs (Institute for International Research) – Boston, MA September 18, 2012 – New USPTO Rules for Post-Grant Proceedings (Strafford) – 1:00 – 2:30 pm (EDT) September 18, 2012 – Supplemental Examination: Rules and Strategy (Intellectual Property Owners Association ) – 2:00 – 3:00 pm September 19,…
-
American Conference Institute (ACI) will be holding its 14th Advanced Forum on Biotech Patents on November 28-29, 2012 in Boston, MA. The conference will allow attendees to: • Prepare for the impending first-to-file regime and decide whether to file under the old or new patent code;• Analyze the outcome in Prometheus and its impact on…
Patent Docs 